Direct activation of TERT transcription by c-MYC
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The MYC proto-oncogene encodes a ubiquitous transcription factor (c-MYC) involved in the control of cell proliferation and differentiation. Deregulated expression of c-MYC caused by gene amplification, retroviral insertion, or chromosomal translocation is associated with tumorigenesis. The function of c-MYC and its role in tumorigenesis are poorly understood because few c-MYC targets have been identified. Here we show that c-MYC has a direct role in induction of the activity of telomerase, the ribonucleoprotein complex expressed in proliferating and transformed cells, in which it preserves chromosome integrity by maintaining telomere length. c-MYC activates telomerase by inducing expression of its catalytic subunit, telomerase reverse transcriptase (TERT). Telomerase complex activity is dependent on TERT, a specialized type of reverse transcriptase. TERT and c-MYC are expressed in normal and transformed proliferating cells, downregulated in quiescent and terminally differentiated cells, and can both induce immortalization when constitutively expressed in transfected cells. Consistent with the recently reported association between MYC overexpression and induction of telomerase activity, we find here that the TERT promoter contains numerous c-MYC-binding sites that mediate TERT transcriptional activation. c-MYC-induced TERT expression is rapid and independent of cell proliferation and additional protein synthesis, consistent with direct transcriptional activation of TERT. Our results indicate that TERT is a target of c-MYC activity and identify a pathway linking cell proliferation and chromosome integrity in normal and neoplastic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of hTERT transcription is driven by the c-Myc oncogene forming a heterodimer, c-Myc/Max, that binds to E-box sequences in the promoter of hTERT [248,249,250]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [248]
In the citing paper
“The TERT promoter is controlled in some contexts by the c-Myc oncogene, which recognizes E-boxes within the promoter (56,57), and by estrogen receptor and Sp1 (58).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [56]
In the citing paper
“There are at least five GC-boxes within the core promoter of hTERT, proven by EMSA to bind Sp1.(22) Introduction of mutations in these GC-boxes significantly decreased the transcriptional activity of the promoter, while overexpression of Sp1 in cells that contain relatively low levels of endogenous Sp1 enhanced the promoter activity.(17)”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
In the citing paper
“In fact, several groups confirmed that c-Myc binds to E-boxes on the hTERT promoter and activates the transcription (15)(16)(17)(18)(19) which established the scenario that c-Myc is a key regulator of hTERT transcription during carcinogenesis.”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“Contrary to early reports suggesting a specific association between telomerase activity and cell immortalization or transformatio”
BackgroundExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Self-citationMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
Self-citationLuciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 781
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
Ayer, D. E., Kretzner, L., & Eisenman, R. N. (1993) · Cell · doi:10.1016/0092-8674(93)90661-9 · Cited by 703
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
Cited by
Items 601–700 of 911
Chromosomal and telomeric reprogramming following ES-somatic cell fusion
Sümer, H., Nicholls, C., Pinto, A. R., Indraharan, D., Liu, J., Lim, M. L., Liu, J., & Verma, P. J. (2009) · Chromosoma · doi:10.1007/s00412-009-0245-1 · Cited by 16
Fiorito, F., Cantiello, A., Granato, G. E., Marfè, G., Ciarcia, R., Florio, S., Pagnini, U., Martino, L. D., & Iovane, G. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.06.020 · Cited by 16
KSHV manipulation of the cell cycle and apoptosis
Moore, P. S. (2007) · Europe PMC (PubMed Central) · Cited by 17
Hidema, S., Fukuda, T., Date, S., Tokitake, Y., Matsui, Y., Sasaki, H., & Nishimori, K. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1191330 · Cited by 16
Telomere Maintenance in Pediatric Cancer
Ackermann, S., & Fischer, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235836 · Cited by 16
Lee, D., Lind, L., Jacobs, D. R., Salihović, S., van Bavel, B., & Lind, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095937 · Cited by 17
MYC amplification and TERT expression in breast tumor progression
Böðvarsdóttir, S. K., Steinarsdóttir, M., Hilmarsdóttir, H., Jonasson, J. G., & Eyfjord, J. E. (2007) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2007.04.002 · Cited by 16
Molecular genetics of acute lymphoblastic leukemia
Ferrando, A. A., Rubnitz, J. E., & Look, A. T. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.011 · Cited by 16
Enhanced activity of cloned hamster TERT gene promoter in transformed cells
Guo, W., Okamoto, M., Lee, Y., Baluda, M. A., & Park, N. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00306-7 · Cited by 16
FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer
Tang, Q., Liu, C., Zhang, S., He, L., Liu, Y., Wang, J., Zhao, X., & Li, X. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100863 · Cited by 16
Zhang, F., Wang, S., & Zhu, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012130 · Cited by 15
Dai, W., Chen, H., Yu, R., He, L., Chen, B., & Chen, X. (2010) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-010-0645-8 · Cited by 15
Sumida, T., & Hamakawa, H. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00132-9 · Cited by 18
c-Myc interacts with TRF1/PIN2 and regulates telomere length
Kim, H., & Chen, J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.064 · Cited by 15
Telomerase as a new target for pancreatic cancer treatment
Sato, N., Mizumoto, K., Nagai, E., & Tanaka, M. (2002) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s005340200036 · Cited by 16
Zakaria, M. K., Khan, I., Mani, P., Chattopadhyay, P., Sarkar, D. P., & Sinha, S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-582 · Cited by 16
Association between mutant IDHs and tumorigenesis in gliomas
Ohba, S., & Hirose, Y. (2018) · Medical Molecular Morphology · doi:10.1007/s00795-018-0189-8 · Cited by 15
Suppression of PROX1‐mediated TERT expression in hepatitis B viral hepatocellular carcinoma
Kim, Y., Yoo, J. E., Jeon, Y., Chong, J. U., Choi, G. H., Song, D., Jung, S. H., Oh, B., & Park, Y. N. (2018) · International Journal of Cancer · doi:10.1002/ijc.31731 · Cited by 15
AMP-activated protein kinase regulates the expression of human telomerase reverse transcriptase
Jo, D., Park, R., Kim, H.-J., Jang, M., Lee, E., Jang, I., & Park, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207864 · Cited by 16
Telomerase reverse transcriptase promoter mutations in hepatocellular carcinogenesis
Ma, Z.-X., Yang, C., Li, M., & Tu, H. (2019) · Hepatoma Research · doi:10.20517/2394-5079.2018.104 · Cited by 15
c‐Myc controls the fate of neural progenitor cells during cerebral cortex development
Wang, X.-L., Ma, Y.-X., Xu, R.-J., Ma, J.-J., Zhang, H.-C., Qi, S.-B., Xu, J.-H., Qin, X.-Z., Zhang, H.-N., Liu, C., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29297 · Cited by 10
Neural stem cells lose telomerase activity upon differentiating into astrocytes
Miura, T., Katakura, Y., Yamamoto, K., Uehara, N., Tsuchiya, T., Kim, E. H., & Shirahata, S. (2001) · Cytotechnology · doi:10.1023/a:1014016315003 · Cited by 15
Song, J.-S. (2004) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.68.1634 · Cited by 15
Chen, C.-J., Tsai, N.-M., Liu, Y.-C., Ho, L., Hsieh, H.-F., YEN, C.-Y., & Hj, H. (2002) · European Journal of Surgical Oncology · doi:10.1053/ejso.2001.1237 · Cited by 15
Yoon, S.-L., Jung, S., Do, E., Lee, S.-R., Lee, S.-Y., Chu, I., Kim, W., Jung, J., Kim, C., Cheon, S.-H., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-393 · Cited by 15
Fujimoto, R., Kamata, N., Taki, M., Yokoyama, K., Tomonari, M., Nagayama, M., & Yasumoto, S. (2003) · Oral Oncology · doi:10.1016/s1368-8375(03)00003-4 · Cited by 15
ZHOU, X., Lu, J., & Zhu, H. (2015) · Oncology Letters · doi:10.3892/ol.2015.3892 · Cited by 15
Finnon, P., Wong, H.-P., Silver, A. R., Slijepčević, P., & Bouffler, S. D. (2001) · International Journal of Radiation Biology · doi:10.1080/09553000110075220 · Cited by 16
Lee, J., Lee, S.-Y., Lee, J., & Lee, S. (2010) · Molecules and Cells · doi:10.1007/s10059-010-0131-y · Cited by 16
Low telomerase activity: Possible role in the progression of human medullary thyroid carcinoma
Stadler, G., Wieser, M., Streubel, B., Stift, A., Friedl, J., Gnant, M., Niederle, B., Beham, A., Katinger, H. W. D., Pfragner, R., et al. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.12.014 · Cited by 16
Transcript Regulation of Human Telomerase Reverse Transcriptase by c-myc and mad1
Zou, L., Zhang, P., Luo, C.-L., & Tu, Z. (2005) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/37.1.32 · Cited by 15
Immortalization of human WI38 cells is associated with differential activation of the c‐myc origins
Tao, L., Dong, Z., Zannis‐Hadjopoulos, M., & Price, G. B. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1173 · Cited by 15
Akiyama, M., Yamada, O., Akita, S., Urashima, M., Horiguchi‐Yamada, J., Ohno, T., Mizoguchi, H., Yoshikatsu, E. T. O., & Yamada, H. (2015) · Leukemia · doi:10.1038/leu.2015.266 · Cited by 15
Canonical Signaling Pathways in Melanoma
Sun, L., & Arbesman, J. (2021) · Clinics in Plastic Surgery · doi:10.1016/j.cps.2021.05.002 · Cited by 16
NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
Gao, E., Sun, X., Thorne, R. F., Zhang, X. D., Li, J., Shao, F., Ma, J., & Wu, M. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04232-1 · Cited by 16
Chaotic aging: intrinsically disordered proteins in aging-related processes
Manyilov, V. D., Ilyinsky, N. S., Nesterov, S. V., Saqr, B. M. G. A., Dayhoff, G. W., Zinovev, E. V., Matrenok, S. S., Fonin, A. V., Kuznetsova, I. M., Turoverov, K. K., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04897-3 · Cited by 14
Prognostic and predictive biomarkers in paediatric solid tumours
Glembocki, A. I., & Somers, G. R. (2023) · Pathology · doi:10.1016/j.pathol.2023.11.007 · Cited by 14
Chang Ming, F. A. N. G., Shi, C., & Xu, Y. (1999) · Cell Research · doi:10.1038/sj.cr.7290029 · Cited by 14
Akiyama, M., Kawano, T., Mikami-Terao, Y., Agawa-Ohta, M., Yamada, O., Ida, H., & Yamada, H. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.11.002 · Cited by 14
Telomerase activity in sputum and telomerase and its components in biopsies of advanced lung cancer
Pasrija, T., Srinivasan, R., Behera, D., & Majumdar, S. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.04.003 · Cited by 16
Jiang, S., Galindo, M. R., & Jarrett, H. W. (2009) · PROTEOMICS · doi:10.1002/pmic.200800693 · Cited by 14
Fascinating Chemopreventive Story of Wogonin: A Chance to Hit on the Head in Cancer Treatment
Kumar, R., Harilal, S., Parambi, D. G. T., Narayanan, S. E., Uddin, M. S., Marathakam, A., Jose, J., Mathew, G. E., & Mathew, B. (2020) · Current Pharmaceutical Design · doi:10.2174/1385272824999200427083040 · Cited by 15
Telomerase and the endocrine system
Pacini, F., Cantara, S., Capezzone, M., & Marchisotta, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.52 · Cited by 16
Targeting Myc in Pediatric Malignancies of the Central and Peripheral Nervous System
Grotzer, M. A., Castelletti, D., Fiaschetti, G., Shalaby, T., & Arcaro, A. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787580962 · Cited by 17
Mukhopadhyay, N. K., Gordon, G. J., Maulik, G., Doerre, G., Liu, B. C. ‐., Bueno, R., Sugarbaker, D. J., & Jaklitsch, M. T. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00496.x · Cited by 14
p14ARF interacts with N‐Myc and inhibits its transcriptional activity
Amente, S., Gargano, B., Diolaiti, D., Valle, G. D., Lania, L., & Majello, B. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.062 · Cited by 14
Telomere Reprogramming and Cellular Metabolism: Is There a Link?
Rubtsova, M. P., Никишин, Д. А., Vyssokikh, M. Y., Koriagina, M. S., Vasiliev, A. V., & Dontsova, O. А. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910500 · Cited by 15
Bilsland, A. E., Stevenson, K. H., Liu, Y., Hoare, S. F., Cairney, C. J., Roffey, J., & Keith, W. N. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003448 · Cited by 16
Amin, A., Morello, M., Petrara, M. R., Rizzo, B., Argenton, F., Rossi, A. D., & Giunco, S. (2023) · Cancers · doi:10.3390/cancers15102673 · Cited by 13
Retinoic acid-induced downmodulation of telomerase activity in human cancer cells
Xiao, X., Sidorov, I. A., Gee, J., Lempicki, R. A., & Dimitrov, D. S. (2005) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.06.001 · Cited by 13
Ahn, E. H., Yang, H. S., Hsieh, C., Sun, W., Chang, C., & Schroeder, J. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4641 · Cited by 13
Saha, P., Kumar, Y. P., Das, T., Müller, D., Bessi, I., Schwalbe, H., & Dash, J. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00655 · Cited by 13
Pan, X., LIU, X. J., Li, J., Zhen, S. J., Liu, D., Feng, Q., Zhao, W. X., Luo, Y., Zhang, Y., Li, H. W., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.74 · Cited by 13
Hájek, M., Votruba, I., Holý, A., Krečmerová, M., & Tloušťová, E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.10.018 · Cited by 13
Simmons, C. D., Pabona, J. M. P., Zeng, Z., Velarde, M. C., Gaddy, D., Simmen, F. A., & Simmen, F. A. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0474 · Cited by 13
Akiyama, M., Yamada, O., Akita, S., Urashima, M., Horiguchi‐Yamada, J., Ohno, T., Mizoguchi, H., Yoshikatsu, E. T. O., & Yamada, H. (2000) · Leukemia · doi:10.1038/sj.leu.2401828 · Cited by 13
Absence of telomerase activity and telomerase catalytic subunit mRNA in melanocyte cultures
Dhaene, K., Vancoillie, G., Lambert, J., Naeyaert, J. M., & Marck, E. V. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1041 · Cited by 13
Eitsuka, T., Nakagawa, K., & Miyazawa, T. (2004) · BioFactors · doi:10.1002/biof.552210105 · Cited by 13
TELOMERE-INDEPENDENT REDUCTION OF HUMAN B LYMPHOCYTE: PROLIFERATION DURING LONG-TERM CULTURE
Jung, D., Néron, S., Lemieux, R., Roy, A., & Richard, M. (2001) · Immunological Investigations · doi:10.1081/imm-100104023 · Cited by 14
Noncanonical functions of telomerase and telomeres in viruses‐associated cancer
Rasouli, S., Dakic, A., Wang, Q., Mitchell, D., Blakaj, D. M., Putluri, N., Li, J., & Liu, X. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29665 · Cited by 14
Han, X., Ren, C., Lu, C., Jiang, A., Wang, X., Liu, L., & Yu, Z. (2024) · Oncogene · doi:10.1038/s41388-024-03097-y · Cited by 12
Liu, X., Wang, J., Wu, L., Trinh, B., & Tsai, R. Y. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115992 · Cited by 13
Sakakibara, A., Tsukuda, M., Kondo, N., Ishiguro, Y., Kimura, M., Fujita, K., Takahashi, H., & Matsuda, H. (2011) · Auris Nasus Larynx · doi:10.1016/j.anl.2011.01.018 · Cited by 12
Wormald, S., Milla, L., & O’Connor, L. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-43 · Cited by 12
Huang, P., Li, R., Shen, L., He, W., Chen, S., Dong, Y., Ma, J., Chen, X., & Xu, M. M. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920933029 · Cited by 12
Polymorphic tandem DNA repeats activate the human telomerase reverse transcriptase gene
Xu, T., Cheng, D., Zhao, Y., Zhang, J., Zhu, X., Zhang, F., Chen, G., Wang, Y., Yan, X., Robertson, G. P., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019043118 · Cited by 12
The Regulation of Telomerase in Oncogenesis
Skvortzov, D. A., Rubzova, M. P., Zvereva, M. I., Fl, K., & Donzova, O. A. (2009) · Acta Naturae · doi:10.32607/20758251-2009-1-1-51-67 · Cited by 18
Wang, Q., Bai, Z., Li, X., Hou, L., & Zhang, B. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.03.032 · Cited by 14
Regulation studies of telomerase gene in cancer cells by lentinan.
Sreenivasulu, K., Vijayalakshmi, M., & Sambasivarao, K. R. (2010) · PubMed Central · Cited by 13
Neoplastic transformation of human diploid fibroblasts after long-term serum starvation
Zhang, J., Wang, X., Zhao, Y., Chen, B., Suo, G., & Dai, J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.022 · Cited by 12
TERT Genetic Mutations as Prognostic Marker in Glioma
Geng, P., Zhao, X., Ou, J., Li, J., Sa, R., & Liang, H. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9930-2 · Cited by 12
Zhu, K., Qu, D., Sakamoto, T., Fukasawa, I., Hayashi, M., & Inaba, N. (2007) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-007-0423-4 · Cited by 12
Non-Canonical TERT Activity Initiates Osteogenesis in Calcific Aortic Valve Disease
Cuevas, R. A., Hortells, L., Chu, C. C., Wong, R., Crane, A., Boufford, C. K., Regan, C., Moorhead, W. J., Bashline, M. J., Parwal, A., et al. (2025) · Circulation Research · doi:10.1161/circresaha.122.321889 · Cited by 11
Canonical and non-canonical functions of the non-coding RNA component (TERC) of telomerase complex
Cao, C., Gong, W., Shuai, Y., Rasouli, S., Ge, Q., Anam Qadir, K. H. A. N., Dakic, A., Putluri, N., Shvets, G. B., Zheng, Y., et al. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01367-0 · Cited by 13
Targeting oncogenic TERT promoter variants by allele-specific epigenome editing
Kouroukli, A. G., Rajaram, N., Bashtrykov, P., Kretzmer, H., Siebert, R., Jeltsch, A., & Bens, S. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01599-2 · Cited by 11
Biology and Pathology of Pediatric Non-Hodgkin Lymphoma
Perkins, S. L., & Morris, S. W. (2007) · Springer eBooks · doi:10.1007/978-3-540-68753-5_6 · Cited by 15
Rossetti, L., D’Isa, G., Mauriello, C., Varra, M., Santis, P. D., Mayol, L., & Savino, M. (2007) · Biophysical Chemistry · doi:10.1016/j.bpc.2007.05.009 · Cited by 11
Expression of Human Telomerase Reverse Transcriptase in Lymphangioleiomyomatosis
Kumaki, F., Takeda, K., Yu, Z., Moss, J., & Ferrans, V. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105045 · Cited by 11
Regulators of Telomerase Activity
Mauro, L. J., & Foster, D. N. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.5.f238 · Cited by 13
(2022) · doi:10.1101/2022.08.23.504425 · Cited by 11
Tian, X.-X., Pang, J. C.-S., Zheng, J., Chen, J., To, S. S. T., & Ng, H.-K. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600244 · Cited by 10
“Wu et al (1999) has demonstrated that c-myc, a downstream target of EGFR, can directly activate telomerase by inducing expression of the catalytic subunit of hTERT.”
BackgroundLiu, M., Hu, Y., Zhu, L., Chen, C., Zhang, Y., Sun, W., & Zhou, Q. (2012) · Journal of Biomedical Research · doi:10.7555/jbr.26.20110078 · Cited by 11
Neuroblastoma Pathology and Classification for Precision Prognosis and Therapy Stratification
Shimada, H., & Ikegaki, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812005-7.00001-1 · Cited by 10
KSHV manipulation of the cell cycle and programmed cell death pathways
Moore, P. S. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.031 · Cited by 10
Horikawa, I., Michishita, E., & Barrett, J. C. (2004) · Cytotechnology · doi:10.1007/s10616-004-5122-4 · Cited by 10
Dual regulation of TERT activity through transcription and splicing by ΔNP63α
Vorovich, E. B., & Ratovitski, E. A. (2008) · Aging · doi:10.18632/aging.100003 · Cited by 10
Vervoorts, J., & Lüscher, B. (1999) · Biological Chemistry · doi:10.1515/bc.1999.140 · Cited by 9
Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data
Tornesello, M. L., Tornesello, A. L., Starita, N., Cerasuolo, A., Izzo, F., Buonaguro, L., & Buonaguro, F. M. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2147062 · Cited by 9
Therapeutic targeting of PLK1 in TERT promoter‐mutant hepatocellular carcinoma
Tang, Q., Hu, G., Sang, Y., Chen, Y., Wei, G., Zhu, M., Chen, M., Li, S., Liu, R., & Peng, Z. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1703 · Cited by 9
Sablin, M., Gestraud, P., Jonas, S. F., Lamy, C., Lacroix‐Triki, M., Bachelot, T., Filleron, T., Lacroix, L., Tran-Dien, A., Jézéquel, P., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02804-6 · Cited by 9
Bisson, F., Paquet, C., Bourget, J., Zaniolo, K., Rochette, P. J., Landreville, S., Damour, O., Boudreau, F., Auger, F. A., Guérin, S. L., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24706 · Cited by 9
Wahlström, T., Belikov, S. V., & Arsenian‐Henriksson, M. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.07.004 · Cited by 10
Helicobacter pylori Induces a Novel NF-kB/LIN28A/let-7a/hTERT Axis to Promote Gastric Carcinogenesis
Li, S., Zeng, J., Ma, L., Li, S., Chen, C., Jia, J., & Liang, X. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0678 · Cited by 9
Wang, W.-L., Yeh, Y.-T., Chen, L.-J., & Chiu, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.049 · Cited by 11
Cheng, Y., Hong, M., & Cheng, B. (2014) · PubMed · Cited by 9
Theophile, K., Buesche, G., Kreipe, H. H., & Bock, O. (2007) · Annals of Hematology · doi:10.1007/s00277-007-0424-1 · Cited by 10
Noronha, E. J., Sterling, K. H., & Calame, K. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306629200 · Cited by 10
Proctor, A., Brownhill, S. C., & Burchill, S. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.011 · Cited by 9
Replicative Senescence and Cancer
Hornsby, P. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-23962-6_3 · Cited by 11
Cell Therapy, Stem Cells, and Brain Repair
Sanberg, C. D., & Sanberg, P. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-147-5 · Cited by 9
Metadata
- Authors
- Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R.
- Affiliations
- Columbia University (US)
- Fred Hutch Cancer Center (US)
- ISREC Foundation (CH)
- Helmholtz Munich (DE)
- Venue
- Nature Genetics
- Published
- 1999-02
- Volume
- 21
- Issue
- 2
- Pages
- 220-224
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/6010
- OpenAlex
- W1547608553
- Cited by
- 893
- References
- 30
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 25 · 2023: 20 · 2022: 24 · 2021: 24 · 2020: 28 · 2019: 21 · 2018: 21 · 2017: 27 · 2016: 31 · 2015: 33 · 2014: 28 · 2013: 26 · 2012: 28
- FWCI
- 32.25
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca037165-17, 5r29ca075125-05)
- National Cancer Institute (CA-20525, CA37165, CA75125-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, telomerase reverse transcriptase, telomerase activation, transcriptional activation, MYC target genes, telomere length, chromosome integrity, cell proliferation, cell immortalization, carcinogenesis
- MeSH terms
- Proto-Oncogene Mas, Binding Sites, Cell Line, DNA-Binding Proteins, Humans, Promoter Regions, Genetic, Proteins, RNA, Transcription, Genetic, Genes, myc, Proto-Oncogene Proteins c-myc, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.